SPEX Share Price

Open 1.23 Change Price %
High 1.23 1 Day -0.01 -0.81
Low 1.15 1 Week 0.06 5.17
Close 1.22 1 Month 0.26 27.08
Volume 35533 1 Year 1.07 713.33
52 Week High 4.69
52 Week Low 0.00
SPEX Important Levels
Resistance 2 1.29
Resistance 1 1.26
Pivot 1.20
Support 1 1.18
Support 2 1.15
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ETRM 0.07 0.00%
AAPL 113.86 1.55%
AAPL 113.86 1.55%
More..
NASDAQ USA Top Gainers Stocks
HTCO 11.00 62.96%
LOCM 0.09 50.00%
OPXA 1.21 40.70%
QKLS 0.18 38.46%
ZAZA 0.08 33.33%
MOSY 0.46 31.43%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
PPHM 0.40 25.00%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
BGMD 0.05 -37.50%
More..

Spherix Incorporated (NASDAQ: SPEX)

SPEX Technical Analysis 1.5
As on 9th Dec 2016 SPEX Share Price closed @ 1.22 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.49 & Buy for SHORT-TERM with Stoploss of 1.15 we also expect STOCK to react on Following IMPORTANT LEVELS.
SPEX Target for December
1st Target up-side 1.47
2nd Target up-side 1.71
3rd Target up-side 1.95
1st Target down-side 0.79
2nd Target down-side 0.55
3rd Target down-side 0.31
SPEX Other Details
Segment EQ
Market Capital 1534951.50
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.spherix.com
SPEX Address
SPEX
7927 Jones Branch Drive
Suite 3125
Tysons Corner, VA 22102
United States
Phone: 703-992-9260
SPEX Latest News
Investor Chatter: Tracking Technical Indicators for Spherix Inc. (SPEX)   MicroCap Wired   - 09th Dec 16
Shares of Spherix, Inc. (NASDAQ:SPEX) Skyrocket on News of Patent Infringement ...   Duncan Research   - 20th Oct 16
Spherix Provides Update on Patent Infringement Litigation   PR Newswire (press release)   - 17th Oct 16
Spherix Monetization Program Continues to Expand   PR Newswire (press release)   - 18th Aug 16
Equitable IP Files Three Patent Infringement Lawsuits Asserting Standard ...   PR Newswire (press release)   - 16th Aug 16
Spherix Inc. (NASDAQ: SPEX)'s Chief Explains $4.38 Million License Deal ...   Scibility Media   - 25th May 16
CEOLIVE.TV Announces New Interview With Anthony Hayes, CEO of Spherix, Inc.   Marketwired (press release)   - 06th May 16
Spherix Inc (SPEX) Subsidiary Begins Patent Litigation Against Huawei   StreetInsider.com (subscription)   - 10th Jun 14
How Spherix Inc. Could Be Valued At $14-$61 Per Share   Seeking Alpha   - 31st Jul 13
Spherix Inc. SPEX (US: Nasdaq)   Wall Street Journal   - 12th Feb 11
Interactive Technical Analysis Chart Spherix Incorporated ( SPEX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Spherix Incorporated
SPEX Business Profile
Spherix Incorporated (Spherix) is a scientific research company. The Company is engaged in developing biopharmaceutical products and providing technical and regulatory consulting services to food, consumer products and pharmaceutical companies. The Company operates in two segments: Biospherics Incorporated (Biospherics), the Company's biotechnology research and development business, and Health Sciences, a technical and regulatory consulting business. The Company has created two wholly owned subsidiaries, Biospherics Incorporated and Spherix Consulting, Inc. (Spherix Consulting), for its two operating segments. The Company's Health Sciences contracts are in the name of Spherix Consulting, and the Company's patents are in the name of Biospherics Incorporated. Spherix provides management, strategic guidance, business development, marketing and other services to its subsidiaries. In September 2013, Spherix Incorporated closed on the acquisition of North South Holdings Inc.